MedTrace Logo

Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients

NCT01756170 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-04-28

No results posted yet for this study

Summary

This phase III study is designed to examine if low-risk (lymph node negative), stage I a2-II b cervical cancer patients treated by paclitaxel/cisplatin chemoradiation have greater toxicities but similar survival rate as those treated by radiotherapy alone.

Conditions

Interventions

DRUG

paclitaxel

DRUG

cisplatin

RADIATION

Radiotherapy

Sponsors & Collaborators

  • xie congying

    lead OTHER

Principal Investigators

  • Congying Xie, MD · the 1st Affiliated Hospital of Wenzhou Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01756170 on ClinicalTrials.gov